mdxhealth
Abhisek Ghosal, Ph.D., is a highly skilled scientist with extensive experience in product development and research within the biotechnology and clinical assay sectors. Currently serving as a Product Development Scientist at mdxhealth since September 2024, Abhisek has previously held significant roles at Lucid Diagnostics, contributing as a Principal Scientist and Senior Scientist in NGS Product Development, and at NeoGenomics Laboratories in positions focused on clinical assay development. Abhisek's career began at ResearchDx, where expertise in next-generation sequencing method development was established, followed by foundational work at PRODO LABORATORIES, INC. in cell biology and therapeutic application. Abhisek has also contributed to molecular biology research as an Assistant Project Scientist at UC Irvine, focusing on vitamin transporters in pancreatic beta cells. Educational credentials include a Ph.D. in Biochemistry and Molecular Biology from NICED-Jadavpur University, along with advanced studies at UC Irvine and certifications in regulatory affairs.
This person is not in any teams
mdxhealth
Mdxhealth is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The company's tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, and prediction of response to a specific therapy. The Company's European headquarters are in Herstal, Belgium, with laboratory operations in Nijmegen, The Netherlands, and US headquarters and laboratory operations based in Irvine, California.